After spending a combined 50+ years in life sciences in both academia and industry, Steve Kuemmerle and Michael Rosen are helping put Rosalind Franklin on the bioscience industry map with a new state-of-the-art research park slated to open this...
In support of young scientists making strides in translational research, Halo is recognizing 40 scientists under 40 in Chicagoland. Nominate a deserving researcher.
Lynn O'Connor Vos, CEO of Muscular Dystrophy Association, discusses its role as both traditional backer of research and now as aggregator of genetic and clinical data that can help uncover new treatments
For the past 17 years, Bruce Bloom, MD, CEO of Cures within Reach, has been proselytizing the virtues of drug repurposing while helping to advance treatments for more than a dozen diseases. Here's why drug repurposing can be a cheaper, faster and...
Harold Steltzer took the unusual step of canvassing university patent coffers for innovation he could spin out into a company. The fruit of his efforts is NoMo Diagnostics, a smart helmet that detects a concussion on-the-field in real-time.
Andrea Domenighetti at the Shirley Ryan AbilityLab discovered an FDA-approved cancer drug can slow muscle contractures in cerebral palsy. Now he's at a crossroads.
Alan Koncarevic, Director of Industry Relations at Polsky, is creating the blueprint for how universities can work with industry and advance their common interests.
Biotech entrepreneur Andy Mazar says Chicago can become an even bigger city in biotech. We just need these key ingredients.
On October 25 at the Halo Awards, we honored three of Chicago's "Heroes of Medicine" working to turn their research into treatments.
Every year the brightest minds in biotech descend up San Francisco. Find the best networking receptions and where Chicago Biotech is hosting.